For the year ending 2025-12-31, OBIO has $114,857K in assets. $51,479K in debts. $34,690K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 34,690 | |||
| Marketable securities | 71,822 | |||
| Accounts receivable, net | 95 | |||
| Inventory | 310 | |||
| Prepaid expenses and other current assets | 994 | |||
| Total current assets | 107,911 | |||
| Property and equipment, net | 1,715 | |||
| Right-of-use assets | 1,496 | |||
| Strategic investments | 2,495 | |||
| Deposits and other assets | 1,240 | |||
| Total assets | 114,857 | |||
| Accounts payable | 6,095 | |||
| Accrued expenses and other liabilities | 9,890 | |||
| Operating lease liability, current portion | 751 | |||
| Total current liabilities | 16,736 | |||
| Royalty purchase agreement | 16,482 | |||
| Loan payable | 14,268 | |||
| Derivative liability | 2,749 | |||
| Operating lease liability, less current portion | 936 | |||
| Other long-term liabilities | 308 | |||
| Total liabilities | 51,479 | |||
| Series a preferred stock, 0.0001 par value per share 200,000 issued and outstanding at december 31, 2025 and 0 issued and outstanding at december 31, 2024 aggregate liquidation preference of 20,000 at december 31, 2025 | 9,808 | |||
| Common stock, 0.0001 par value per share 340,000,000 shares authorized 57,032,963 and 38,194,442 shares issued and outstanding as of december 31, 2025 and december 31, 2024, respectively | 6 | |||
| Additional paid-in capital | 416,083 | |||
| Accumulated other comprehensive income | 60 | |||
| Accumulated deficit | -362,579 | |||
| Total stockholders' equity | 53,570 | |||
| Total liabilities, series a preferred stock and stockholders' equity | 114,857 | |||
Orchestra BioMed Holdings, Inc. (OBIO)
Orchestra BioMed Holdings, Inc. (OBIO)